
Invectys Inc. to Participate in the 9TH International C...
9th International Conference on HLA-G July 4th – 5th 2022 Fondation Singer-Polignac, 43 Avenue Georges Mandel, 75116 Paris Invectys will be…
9th International Conference on HLA-G July 4th – 5th 2022 Fondation Singer-Polignac, 43 Avenue Georges Mandel, 75116 Paris Invectys will be…
Invectys, MD Anderson and CTMC Announce Strategic Collaboration for CAR T Cell Therapy Development Houston, Texas, USA – June 16, 2022 – Invectys, Inc. (Invectys),…
Invectys, Inc. Appoints François Lescure as General Manager of its R&D Subsidiary, Invectys, SAS Houston, Texas, USA – April 11, 2022 (GLOBE NEWSWIRE) –…
Monoclonal antibodies targeting checkpoint inhibitors are hugely important immunotherapy molecules for the treatment cancers…
The telomerase enzyme functions as part of a large ensemble of proteins and RNA called the telomerase ribonucleoprotein complex.…
The main product of Invectys is a DNA vaccine targeting Telomerase…